newsfilter
← Latest News
Business Wire·

Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia

Axonics, Inc. (NASDAQ:AXNX) today announced that it has received regulatory approval from the Therapeutic Goods Administration (TGA) for marketing the Axonics F15™ recharge-free sacral neuromodulation (SNM)